South San Francisco, CA, United States of America

Hong Wang

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Wang. Retrieved from https://idiyas.com/inventor/hong-wang-lg3pnm5i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hong Wang

Introduction

Hong Wang is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work is instrumental in advancing therapeutic options for various diseases.

Latest Patents

Hong Wang holds a patent for "Subcutaneous Dosing of Anti-CD20/Anti-CD3 Bispecific Antibodies." This innovative approach aims to improve the delivery and efficacy of treatments targeting specific immune responses.

Career Highlights

Wang is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious medical conditions. His role at Genentech allows him to collaborate with some of the brightest minds in the industry.

Collaborations

Some of his notable coworkers include Chi-Chung Li and Carol Elaine O'hear. Their combined expertise contributes to the innovative environment at Genentech, fostering advancements in medical research.

Conclusion

Hong Wang's contributions to biotechnology through his patent and work at Genentech highlight his role as a key innovator in the field. His efforts continue to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…